“The development of full artificial intelligence could spell the end of the human race….It would take off on its own, and re-design itself at an ever increasing rate. Humans, who are limited by slow biological evolution, couldn’t compete, and would be superseded.”
Non-alcoholic fatty liver disease
Alternative names for non-alcoholic fatty liver disease include fatty liver, steatosis, non-alcoholic steatohepatitis, and NASH.
Nonalcoholic fatty liver disease (NAFLD) is an umbrella term for various liver conditions affecting people who drink little to no alcohol. As the name implies, the main characteristic of NAFLD is too much fat stored in liver cells.
NAFLD affects up to 25 percent of the global population. For some individuals, undetected non-alcoholic fatty liver disease can lead to liver scarring, cancer, or failure.
Symptoms of advanced scarring (cirrhosis) may include:
Non-alcoholic fatty liver disease typically causes no symptoms. If symptomsoccur, they may include general fatigue or discomfort in the upper right abdomen.
Some individuals with NAFLD develop nonalcoholic steatohepatitis (NASH), an aggressive form of fatty liver disease. With NASH, liver inflammation may progress to advanced scarring (cirrhosis) and liver failure. This damage is similar to the damage caused by heavy alcohol use.
Symptoms may include
- Abdominal swelling (ascites)
- Enlarged blood vessels just beneath the skin’s surface
- Enlarged spleen
- Red palms
- Yellowing of the skin and eyes (jaundice)
Risk factors for non-alcoholic liver disease
NAFLD results from more than normal fat deposits in the liver. Experts don’t know why some people build up fat in the liver while others do not.
Things that may put you at risk include any of the following:
- Being overweight or obese. The more overweight you are, the higher the risk.
- Pre-diabetes (insulin resistance).
- Type 2 diabetes.
- High cholesterol or high triglycerides.
- High blood pressure.
Other risk factors include rapid weight loss and poor diet, gastric bypass surgery, bowel disease, and certain medicines, such as calcium channel blockers and some cancer drugs. NAFLD also occurs in individuals with no known risk factors.
Gut microbiome and fatty liver disease prediction
Let’s look at how researchers developed a model to predict a disease coursebased on the gut’s microbial composition.
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.
In this context, scientists evaluated 1,200 individuals in a community-based cohort. At the study start, no subject had liver disease. The researchers analyzed blood and stool samples.
The researchers followed the subjects for 4.6 years. When re-examined, 90 of the subjects had developed nonalcoholic fatty liver disease. They compared the samples of the affected individuals with a control group of 90 individuals who did not have NAFLD at baseline or the follow-up visit.
After finding subtle differences in the samples from four years prior, the group developed a microbiome-based model to predict NAFLD with 80 percent accuracy.
Machine learning to predict fatty liver disease
The research team created a machine learning model — a computer model trained to recognize specific patterns in a dataset. The model can then use these patterns to analyze new datasets and predict nonalcoholic fatty liver disease for these researchers. The complex process spanned over three years. Voila, a successful tool for predicting nonalcoholic fatty liver disease.
The researchers validated their results using patient data from Europe and the United States. Next, they aim to conduct the study internationally and use artificial intelligence to integrate even larger data sets into the study.
My take: Non-alcoholic fatty liver disease
Given that nonalcoholic fatty liver is irreversible (and sometimes leads to liver cancer), early identification is helpful to counteract the condition’s natural history.
NAFLD is a largely silent disease, so kudos to the brilliant researchers for opening the door to early detection. A study author offers that microbiome-based diagnostics will reach clinical practice in the next ten years.
For now, you may reduce your risk of developing non-alcoholic fatty liver disease with these strategies:
- Maintain a healthy weight.
- Eat a healthy diet.
- Exercise regularly.
- Limit alcohol consumption.
- Use medicines properly.
Thank you for joining me.
The information I provided in this blog is for educational purposes only and does not substitute for professional medical advice. Please consult a medical professional or healthcare provider if you seek medical advice, diagnoses, or treatment. I am not liable for risks or issues associated with using or acting upon the information in this blog.
